Javascript must be enabled to continue!
The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery
View through CrossRef
Preoperative anxiety can increase postoperative pain and is therefore important to avoid. Different approaches have already been tested for preoperative anxiolysis. Gabapentinoids might be a useful alternative to benzodiazepines. Pregabalin is used for treating generalized anxiety disorders and shows a favourable pharmacokinetic profile after oral administration; however, its anxiolytic effect preoperatively in healthy outpatients is still unclear. In this randomised, double-blind, placebo-controlled trial the anxiolytic effect of pregabalin in 40 outpatients undergoing standardised general anaesthesia and postoperative pain therapy for minor orthopaedic surgery was analysed. Patients received preoperatively either 300 mg pregabalin or placebo orally. The primary outcome was anxiety before anaesthesia induction, the secondary outcome the postoperative pain, both assessed using a visual analogue scale from 0 to 100. Without any side effects pregabalin reduced preoperative anxiety compared with the control group (23 ± 10 vs. 38 ± 17; p = 0.003). Pain scores did not differ between groups; however, need of piritramide in the postanaesthesia care unit was reduced to half by pregabalin compared with the control group. A single preoperative dose of 300 mg pregabalin reduces anxiety in patients undergoing minor orthopaedic surgery without any side effects like dizziness or persisting sedation resulting in a prolonged stay in the postanaesthesia care unit.
Title: The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery
Description:
Preoperative anxiety can increase postoperative pain and is therefore important to avoid.
Different approaches have already been tested for preoperative anxiolysis.
Gabapentinoids might be a useful alternative to benzodiazepines.
Pregabalin is used for treating generalized anxiety disorders and shows a favourable pharmacokinetic profile after oral administration; however, its anxiolytic effect preoperatively in healthy outpatients is still unclear.
In this randomised, double-blind, placebo-controlled trial the anxiolytic effect of pregabalin in 40 outpatients undergoing standardised general anaesthesia and postoperative pain therapy for minor orthopaedic surgery was analysed.
Patients received preoperatively either 300 mg pregabalin or placebo orally.
The primary outcome was anxiety before anaesthesia induction, the secondary outcome the postoperative pain, both assessed using a visual analogue scale from 0 to 100.
Without any side effects pregabalin reduced preoperative anxiety compared with the control group (23 ± 10 vs.
38 ± 17; p = 0.
003).
Pain scores did not differ between groups; however, need of piritramide in the postanaesthesia care unit was reduced to half by pregabalin compared with the control group.
A single preoperative dose of 300 mg pregabalin reduces anxiety in patients undergoing minor orthopaedic surgery without any side effects like dizziness or persisting sedation resulting in a prolonged stay in the postanaesthesia care unit.
Related Results
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Abstract
Funding Acknowledgements
Type of funding sources: None.
INTRODUCTION Patients with heart failure (HF)...
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
...
A Prospective Comparative Study on the Effectiveness of Pregabalin and Fixed-Dose Combination of Pregabalin with Methylcobalamin in Painful Peripheral Neuropathy in Diabetic Patients
A Prospective Comparative Study on the Effectiveness of Pregabalin and Fixed-Dose Combination of Pregabalin with Methylcobalamin in Painful Peripheral Neuropathy in Diabetic Patients
Background: Painful diabetic peripheral neuropathy (DPN) is a common and debilitating complication of diabetes mellitus, significantly impairing quality of life. Pregabalin is wide...
Patient Exposure to Pregabalin During Pregnancy: Safe or Unsafe?
Patient Exposure to Pregabalin During Pregnancy: Safe or Unsafe?
Madam,
pregabalin is an anticonvulsant used mainly for the treatment of epilepsy, neuropathic pain, and anxiety. Recently, a safety advisory by the Drug Regulatory Authority of Pak...
Pregabalin in fibromyalgia - responder analysis from individual patient data
Pregabalin in fibromyalgia - responder analysis from individual patient data
Abstract
Background
Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for...
Neurotoxic Assessment of Chronic Abuse of Pregabalin in Wistar Rats
Neurotoxic Assessment of Chronic Abuse of Pregabalin in Wistar Rats
Pregabalin (Lyrica) is an analog of the gamma-aminobutyric acid neurotransmitter, approved for the treatment of epilepsy, generalized anxiety disorder, neuropathic pain, and fibr...
The anxiolytic effects of preoperative administration of pregabalin in comparison to diazepam and placebo
The anxiolytic effects of preoperative administration of pregabalin in comparison to diazepam and placebo
AbstractWe aimed to evaluate the potential anxiolytic effects of premedication with pregabalin, compared with diazepam and placebo. We conducted this non-inferiority, double-blind,...
Hyponatremia Associated with Pregabalin
Hyponatremia Associated with Pregabalin
Objective: To assess if hyponatremia is associated with pregabalin. Pregabalin, an analog of the neurotransmitter γ-aminobutyric acid, possesses analgesic, anticonvulsant, and anxi...

